| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | CEO And CFO
1 company
Reich Samuel J serves as an Executive Chairman at SABS. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $196K at current prices.
The biggest single holding is SABS (~$196K) as Executive Chairman. Net of sales, the recent Form 4 record there shows accumulation of 429,200 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | SABS Sab Biotherapeutics, Inc. | Executive Chairman | Buy | 11,000 | $0.89 | $9,841.70 | +5.3% | -42.5% | -66.4% | |
| Oct 14, 2021 | SABS Sab Biotherapeutics, Inc. | CEO And CFO | Buy | 1,000 | $10.11 | $10,110.00 | New | -25.1% | -92.1% | |
| Jan 14, 2021 | SABS Sab Biotherapeutics, Inc. | CEO And CFO | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% | - | - |